Skip to content

A Study to Examine the Human Gastrointestinal Tract Using the Confocal Endomicroscope

A Pilot Study to Examine the Human Gastrointestinal Tract Using the Confocal Endomicroscope

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01262937
Enrollment
106
Registered
2010-12-20
Start date
2009-07-31
Completion date
2016-07-31
Last updated
2018-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive System Diseases

Keywords

confocal, biliary, esophagus

Brief summary

The goal of the project is to determine whether confocal endomicroscopy can be used to identify and discriminate among dysplastic, neoplastic, and nonneoplastic tissue, as compared with histologic specimens as a reference. The project will evaluate those at risk for or with known Barrett's esophagus, and those with known or suspected biliary strictures. It is our hypothesis that we will be able to identify between neoplastic and nonneoplastic tissue.

Detailed description

This study was amended from it's initial design to increase the number of patients to 200. The study was terminated in July 2016 after 106 patients were enrolled and had completed the study.

Interventions

Confocal imaging performed of the digestive system with the use of confocal miniprobes such as the Gastroflex UHD and Cholangioflex miniprobes (Cellvizio, Mauna Kea, Paris, France)

Sponsors

Yale University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with long-standing reflux symptoms, undergoing surveillance for Barrett's esophagus, or scheduled for endoscopic therapy with esophageal dysplasia * Patients undergoing ERCP for known or suspected biliary strictures.

Exclusion criteria

* have a known allergy or have had a prior adverse reaction to fluorescent contrast agents or chromoendoscopy stains * are younger than age 18 or who are mentally or legally incapacitated or unable to give informed consent * are pregnant or breastfeeding * patients with advanced esophageal cancer * acute gastrointestinal bleeding * coagulopathy * impaired renal function

Design outcomes

Primary

MeasureTime frame
To compare confocal image characteristics between benign and malignant tissue.2 Years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026